Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Elephants Revived a “Zombie” Gene that May Fend Off Cancer

DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.

DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.

science publishing, culture, cancer
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Sukanya Charuchandra | Aug 13, 2018
A San Francisco court levels $289 Million in damages against the pesticide maker.
Studies Unable to Reproduce Results of Two Diabetes Papers
Studies Unable to Reproduce Results of Two Diabetes Papers
Anna Azvolinsky | Aug 10, 2018
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Diana Kwon | Aug 1, 2018
The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.
Officially Intelligent
Officially Intelligent
Bob Grant | Aug 1, 2018
Humanity is on the precipice of major change. Some fear a world ruled by bots. I fear a world ruled by people.
Opinion: Learning from Immunotherapy’s Recent Failures
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Lessons from Biosphere 2
Lessons from Biosphere 2
Mark Nelson | Aug 1, 2018
Both the scientific community and the general public still have a lot to learn from the largest mesocosm research project ever conducted.
Third Retraction for Harvard Cancer Biologist
Third Retraction for Harvard Cancer Biologist
Katarina Zimmer | Jul 25, 2018
The move follows two major corrections to a 2011 Nature paper, in which researchers demonstrated that a natural compound selectively kills cancer cells.
German Scientists Frequently Publish in Predatory Journals
German Scientists Frequently Publish in Predatory Journals
Catherine Offord | Jul 19, 2018
At least 5,000 of the country’s researchers have published their work on questionable platforms, often forking over exorbitant fees, a report finds.
Cancer Geneticist Quits After Harassment Allegations
Cancer Geneticist Quits After Harassment Allegations
Kerry Grens | Jul 17, 2018
Accusations that Nazneen Rahman bullied employees at the Institute of Cancer Research in the U.K. stretch back 12 years.